At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MEDP Medpace
Post-Market Trading 09-16 16:17:13 EDT
356.69
+5.02
+1.43%
盘后356.69
+0.000.00%
16:01 EDT
High357.90
Low351.18
Vol215.30K
Open353.86
D1 Closing351.67
Amplitude1.91%
Mkt Cap11.03B
Tradable Cap9.06B
Total Shares30.93M
T/O76.58M
T/O Rate0.85%
Tradable Shares25.39M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
HQY vs. MEDP: Which Stock Is the Better Value Option?
Berry and Glatfelter Announce Magnera Board of Director Appointments in Connection With Proposed Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business With Glatfelter
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.